Press Resease

Crohn’s Disease Treatment Market - By Procedures (Colonoscopy, Flexible Sigmoidoscopy, Magnetic Resonance Imaging, Computerized Tomography, Capsule Endoscopy, Small Bowel Imaging & Double-Balloon Endoscopy, and Others), By Drug Types (Antibiotics, Anti-Diarrheal, Anti-Inflammatory Drugs Pain Relievers, Immune System Suppressors, and Others), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Published Date: 15-Feb-2021 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3033 Status : Published

The global Crohn’s Disease Treatment market, which was estimated at about 4.5 (USD Billion) in 2018 and is predicted to accrue earnings worth 13.1 (USD Billion) by 2025, is set to record a CAGR of nearly about 3.5% over 2019-2025.

Description

The global Crohn’s Disease Treatment market, which was estimated at about 4.5 (USD Billion) in 2018 and is predicted to accrue earnings worth 13.1 (USD Billion) by 2025, is set to record a CAGR of nearly about 3.5% over 2019-2025. The report offers valuation and analysis of Crohn’s Disease Treatment market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on value (USD Billion).

Crohn’s Disease Treatment Market: Overview

Crohn disease is an inflammatory bowel disease and can impact the gastrointestinal tract. According to NCBI, Crohn’s Disease is genetically associated with phenotype. Researchers at NIH have found that NOD2/CARD15 mutations to be related to crohn’s disorder phenotype that can be determined at young age. Moreover, the ailment is usually observed in North America, New Zealand, and Europe. Apparently, the ailment is one of the major chronic relapsing inflammatory bowel disorders that involve inflammation in digestive system between anus and mouth. Apparently, the infection takes place in colon or ileum or both. Furthermore, NCBI reports that the cases of Crohn’s Disease were found to be falling in the range of nearly two to twenty incidences per one lakh persons since 1980 across the globe.  The disease is impacted by factors such as heredity, immunologic milieu, and environment.

Moreover, the various modes of disease treatment include medicines, nutrient supplements, and surgery. The key aim of treating the disorder is to control inflammation, correct nutritional deficiency, and provide relief to the patients from diarrhea, abdominal pain, and rectal bleeding. Reportedly, the therapy of the ailment is based upon location and seriousness of the crohn’s disorder, its complexities, and medical treatment history for recurring disease symptoms.

Crohn’s Disease Treatment  Market: Growth Dynamics

Rise in the gastrointestinal disease and surge in the proportion of patients affected due to Crohn’s Disease will pave a way for the expansion of Crohn’s Disease Treatment Market in the years ahead. Changes in the lifestyles and improper food habits have resulted in occurrence of crohn’s disease, thereby steering the expansion of Crohn’s Disease Treatment market. Escalating demand for biologics for treating Crohn’s disorder and growing awareness about the ailment will push the expansion of Crohn’s Disease Treatment industry over the assessment period. Moreover, massive use of anti-inflammatory medicines along with rapid adoption of biosimilars will play a prominent role in influencing the expansion of Crohn’s Disease Treatment Market over the forecast timespan. Nonetheless, huge treatment costs will curtail the growth of Crohn’s Disease Treatment industry over the forecast timeline. Apart from this, lack of early diagnosis in emerging economies and expiry of copyrights of blockbuster medicines can hinder the expansion of Crohn’s Disease Treatment market.

Furthermore, massive preference for symptomatic medicines and treatment over surgeries, effective disease management for inflammatory bowel disorders, and arrival of new drugs will mark a new chapter in the domain of Crohn’s Disease Treatment and will steer the industry trends.

North American Market To Attain Highest Growth By 2025

The expansion of Crohn’s Disease Treatment market in North America over 2019-2025 is credited to surge in the number of incidences of disease occurrence witnessed in the region. In addition to this, huge focus of pharma firms on medicine development pertaining to the occurrence of disease in the countries such as the U.S. and Canada will proliferate the expansion of the Crohn’s Disease Treatment industry over the assessment timeline.

Key participants profiled in the study are Allergan, Inc.; Takeda Immune System Suppressors Company Limited; Bayer AG; Novartis International AG; Johnson & Johnson; AbbVie Inc.; Boehringer Ingelheim GmbH; F. Hoffmann-La Roche; Bristol-Myers Squibb; GlaxoSmithKline plc; Eli Lilly and Co.; Janssen Biotech, Inc.; Pfizer Inc.; and Sanofi.    

The global Crohn’s Disease Treatment Market is segmented as follows:

By procedures:

  • Magnetic Resonance Imaging (MRI)
  • Flexible Sigmoidoscopy
  • Colonoscopy
  • Capsule Endoscopy
  • Computerized Tomography (CT)
  • Small Bowel Imaging & Double-Balloon Endoscopy
  • Others

By drug types:

  • Immune System Suppressors
  • Anti-Diarrheal
  • Antibiotics
  • Anti-Inflammatory Drugs Pain Relievers
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Crohn’s Disease Treatment Market, 2015–2025 (USD Billion)
    • 2.2. Crohn’s Disease Treatment Market: Snapshot
  • Chapter 3. Global Crohn’s Disease Treatment Market– Industry Analysis
    • 3.1. Crohn’s Disease Treatment Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rise in the gastrointestinal disease and surge in the proportion of patients affected due to Crohn’s Disease will pave a way for the expansion of Crohn’s Disease Treatment Market in the years ahead.
      • 3.2.2. Escalating demand for biulogics for treating Crohn’s disorder and growing awareness about the ailment will push the expansion of Crohn’s Disease Treatment industry over the assessment period.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Procedures
      • 3.4.2. Market attractiveness analysis By Drug Types
  • Chapter 4. Global Crohn’s Disease Treatment Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Crohn’s Disease Treatment Market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Crohn’s Disease Treatment Market– Procedures Analysis
    • 5.1. Global Crohn’s Disease Treatment Market overview: By Procedures
      • 5.1.1. Global Crohn’s Disease Treatment Market share, By Procedures, 2018 and 2025
    • 5.2. Culonoscopy
      • 5.2.1. Global Crohn’s Disease Treatment Market By Culonoscopy, 2015–2025 (USD Billion)
    • 5.3. Flexible Sigmoidoscopy
      • 5.3.1. Global Crohn’s Disease Treatment Market By Flexible Sigmoidoscopy, 2015–2025 (USD Billion)
    • 5.4. Magnetic Resonance Imaging
      • 5.4.1. Global Crohn’s Disease Treatment Market By Magnetic Resonance Imaging, 2015–2025 (USD Billion)
    • 5.5. Computerized Tomography
      • 5.5.1. Global Crohn’s Disease Treatment Market By Computerized Tomography, 2015–2025 (USD Billion)
    • 5.6. Capsule Endoscopy
      • 5.6.1. Global Crohn’s Disease Treatment Market By Capsule Endoscopy, 2015–2025 (USD Billion)
    • 5.7. Small Bowel Imaging & Double-Balloon Endoscopy
      • 5.7.1. Global Crohn’s Disease Treatment Market By Small Bowel Imaging & Double-Balloon Endoscopy, 2015–2025 (USD Billion)
    • 5.8. Others
      • 5.8.1. Global Crohn’s Disease Treatment Market By Others, 2015–2025 (USD Billion)
  • Chapter 6. Global Crohn’s Disease Treatment Market– Drug Types Analysis
    • 6.1. Global Crohn’s Disease Treatment Market overview: By Drug Types
      • 6.1.1. Global Crohn’s Disease Treatment Market share, By Drug Types , 2018 and 2025
    • 6.2. Antibiotics
      • 6.2.1. Global Crohn’s Disease Treatment Market By Antibiotics, 2015–2025 (USD Billion)
    • 6.3. Anti-Diarrheal
      • 6.3.1. Global Crohn’s Disease Treatment Market By Anti-Diarrheal, 2015–2025 (USD Billion)
    • 6.4. Anti-Inflammatory Drugs Pain Relievers
      • 6.4.1. Global Crohn’s Disease Treatment Market By Anti-Inflammatory Drugs Pain Relievers, 2015–2025 (USD Billion)
    • 6.5. Immune System Suppressors
      • 6.5.1. Global Crohn’s Disease Treatment MarketBy Immune System Suppressors, 2015–2025 (USD Billion)
    • 6.6. Others
      • 6.6.1. Global Crohn’s Disease Treatment MarketBy Others, 2015–2025 (USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Allergan, Inc.
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfulio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. AbbVie Inc.
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfulio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Bristul-Myers Squibb
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfulio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Bayer AG
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfulio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. F. Hoffmann-La Roche
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfulio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Boehringer Ingelheim GmbH
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfulio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. GlaxoSmithKline plc
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfulio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Eli Lilly and Co
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfulio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Johnson & Johnson
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfulio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. Janssen Biotech, Inc.
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product Portfulio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development
    • 7.11. Pfizer Inc.
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Product Portfulio
      • 7.11.4. Business Strategy
      • 7.11.5. Recent Development
    • 7.12. Novartis International AG
      • 7.12.1. Overview
      • 7.12.2. Financials
      • 7.12.3. Product Portfulio
      • 7.12.4. Business Strategy
      • 7.12.5. Recent Development
    • 7.13. Takeda Pharmaceutical Company Limited
      • 7.13.1. Overview
      • 7.13.2. Financials
      • 7.13.3. Product Portfulio
      • 7.13.4. Business Strategy
      • 7.13.5. Recent Development
    • 7.14. Sanofi
      • 7.14.1. Overview
      • 7.14.2. Financials
      • 7.14.3. Product Portfulio
      • 7.14.4. Business Strategy
      • 7.14.5. Recent Development

Methodology


Frequently Asked Questions

Rise in the gastrointestinal disease and surge in the proportion of patients affected due to Crohn’s Disease Treatment Market will pave a way for the expansion of Crohn’s Disease Treatment Market in the years ahead. Changes in the lifestyles and improper food habits have resulted in occurrence of crohn’s disease, thereby steering the expansion of Crohn’s Disease treatment market. Escalating demand for biologics for treating Crohn’s disorder and growing awareness about the ailment will push the expansion of Crohn’s Disease Treatment industry over the assessment period. Moreover, massive use of anti-inflammatory medicines along with rapid adoption of biosimilars will play a prominent role in influencing the expansion of Crohn’s Disease Treatment Market over the forecast timespan.

Furthermore, massive preference for symptomatic medicines and treatment over surgeries, effective disease management for inflammatory bowel disorders, and arrival of new drugs will mark a new chapter in the domain of Crohn’s Disease Treatment Market and will steer the industry trends.

According to Zion Market Research report, the global Crohn’s Disease Treatment  market, which was estimated at about 4.5 (USD Billion) in 2018 and is predicted to accrue earnings worth 13.1 (USD Billion) by 2025, is set to record a CAGR of nearly about 3.5% over 2019-2025.

North America is likely to make noteworthy contributions towards overall Crohn’s Disease Treatment Market revenue over 2019-2025. The growth of the market in the region over estimated timespan can be ascribed to surge in the number of incidences of disease occurrence witnessed in the region. In addition to this, huge focus of pharma firms on medicine development pertaining to the occurrence of disease in the countries such as the U.S. and Canada will proliferate the expansion of the Crohn’s Disease Treatment  industry over the assessment timeline.  

The key players profiled in the report include Allergan, Inc.; Takeda Immune System Suppressors Company Limited; Bayer AG; Novartis International AG; Johnson & Johnson; AbbVie Inc.; Boehringer Ingelheim GmbH; F. Hoffmann-La Roche; Bristol-Myers Squibb; GlaxoSmithKline plc; Eli Lilly and Co.; Janssen Biotech, Inc.; Pfizer Inc.; and Sanofi.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com